[{"Assets_0_Q1_USD":"4435398000.0","CIK":"1048477","CommonStockSharesConverted_0_Q1_shares":"179033104.0","CommonStockSharesOutstanding_0_Q1_shares":"179033104.0","Country":"United States","EarningsPerShareBasic_1_Q1_USD":"-0.32","EarningsPerShareDiluted_1_Q1_USD":"-0.32","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"14899091235.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":"-54868000.0","NetIncomeLossAvailableToCommonStockholdersBasic_1_Q1_USD":"-56473000.0","NetIncomeLoss_1_Q1_USD":"-56473000.0","OfficialName":"BioMarin Pharmaceutical Inc. Common Stock","RevenuesConverted_1_Q1_USD":"400745000.0","SP500":null,"Sector":"Health Care","StockholdersEquity_0_Q1_USD":"2936627000.0","Ticker":"BMRN","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":"178271000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":"178271000.0","filed":"20190429","footnote":null,"form":"10-Q","fp":"Q1","fy":"2019.0","name":"BIOMARIN PHARMACEUTICAL INC","period":"20190331","qtrs":"0","uom":"USD"}]